Task: Answer the multiple choice question.
Query: Which drug exhibits a -16.105% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCN1CCN(c2ccccc2NC(=O)c2ccc(-n3cccn3)cc2)CC1
[b] C/C=C/c1ccc(OCCCCOc2ccc(OC)cc2)c(OC)c1
Answer: a. CCN1CCN(c2ccccc2NC(=O)c2ccc(-n3cccn3)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2ccccc2NC(=O)c2ccc(-n3cccn3)cc2)CC1
CCN1CCN(c2ccccc2NC(=O)c2ccc(-n3cccn3)cc2)CC1
N-[2-(4-ethylpiperazin-1-yl)phenyl]-4-pyrazol-1-ylbenzamide